Pharmaceutical compositions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 3, 2013
Grant Date -
Sep 1, 2011
app pub date -
Jun 25, 2009
filing date -
Jun 25, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The object of the present invention is to provide a pharmaceutical composition that inhibits expression of iNOS and COX-2 without inhibiting NF-κB. The pharmaceutical composition that inhibits expression of iNOS and COX-2 without inhibiting NF-κB contains DTCM glutarimide of the Formula (I) as an effective ingredient, thereby being able to inhibit nitric oxide (NO) production and prostaglandin production.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully